CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES.
D000900:Anti-Bacterial Agents; D035843:Biomedical Research; D002512:Cephalothin; D002648:Child; D003353:Corynebacterium diphtheriae; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004754:Enterobacter; D004926:Escherichia coli; D004927:Escherichia coli Infections; D005853:Geriatrics; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D007709:Klebsiella; D011008:Pneumococcal Infections; D011512:Proteus Infections; D011549:Pseudomonas; D012106:Research; D012475:Salmonella; D012760:Shigella; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013290:Streptococcal Infections; D013291:Streptococcus; D013296:Streptococcus pneumoniae; D014116:Toxicology
D000900:Anti-Bacterial Agents; D002512:Cephalothin
AEROBACTER; ANTIBIOTICS; CEPHALOTHIN; CHILD; CLINICAL RESEARCH; CORYNEBACTERIUM DIPHTHERIAE; DIPLOCOCCUS PNEUMONIAE; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EXPERIMENTAL LAB STUDY; GERIATRICS; HAEMOPHILUS INFLUENZAE; INFANT; KLEBSIELLA; PNEUMOCOCCAL INFECTIONS; PROTEUS INFECTIONS; PSEUDOMONAS; SALMONELLA; SHIGELLA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TOXICOLOGIC REPORT